VML HEALTH’s Post

Discover our latest article on Medium! Uncover the promise of biomarkers in ovarian cancer detection and treatment. From early diagnosis to personalized care, learn how these tiny indicators are shaping the future of treatment. Read now! 👇 https://lnkd.in/eGKQmhVM #OvarianCancer #Biomarkers

🔎Discover the intricate world of cancer biomarkers in our newest Medium article! From diagnosis to treatment monitoring, learn how these versatile indicators are revolutionizing cancer care.👇 https://lnkd.in/d_ri6gim #CancerResearch #PrecisionMedicine #Healthcare

As colorectal cancer is affecting people at a younger age, monitoring minimal residual disease and treatment response is becoming increasingly important. Check out this article on a promising new technology and approach for achieving these goals in a more accessible and cost-effective way. #colorectalcancer #cancerresearch #medicalinnovation Link: https://lnkd.in/gifJKAKn

Every year, #WorldCancerDay is a powerful reminder of the progress Merck Healthcare has made in the fight against this disease and how much more still needs to be done to #CloseTheCareGap - so every patient has access to care. Every day we recommit ourselves to overcoming the many challenges we face to get closer to our vision of helping more patients become cancer survivors. Our chances of finally making this a reality have never been better. Let's continue to drive innovation, harness the unimaginable potential of #AI and technological advancements, and foster diligent approaches across all disciplines to further improve access and, ultimately, patient outcomes: https://lnkd.in/dykv49N2 #AsOneForPatients #Oncology

The article on new treatments for endometrial cancer marks 2024 as a breakthrough year, with immune-based therapies leading to improved outcomes for patients. This shift from traditional therapies highlights the power of checkpoint inhibitors to tackle advanced cases more effectively. 🚀 What’s most exciting is the potential of combination therapies and antibody-drug conjugates, reflecting a trend toward personalised medicine that offers hope for better survival rates. Could we be seeing a new era in cancer treatment? 🌟💊 #BiotechJobs #PharmaRecruitment #QualityAssurance #LifeSciences #HealthcareRecruitment #BiotechCareers

The National Institutes of Health developed an #AI tool that uses routine clinical data, such as from a simple blood test, to predict if #cancer will respond to #immunotherapy drugs. This could help doctors determine if the drugs are effective for treating a patient’s cancer. #MachineLearning #ML #HealthcareInnovation #HealthcareMatters Read more:

Imagine a world where everyone with MBC gets the most effective treatment. #NoOneMissed, a new campaign from Living Beyond Breast Cancer, raises awareness of the importance of biomarker testing and empowers patients to make informed decisions. Learn more: MBCAlliance.org/NOM24

The role of biomarkers in optimizing treatment paradigms is not new. However, in a recent analysis I conducted with Lindsey Gasparini, we demonstrated that nearly 40% of lung cancer patients with PD-L1 expression and an EGFR mutation received an immunotherapy first, against NCCN guidelines. As an industry, we owe it to patients to identify, research, and track these deviations from guidelines. These types of large scale RWD studies are only possible when companies like Komodo Health and NeoGenomics Laboratories work together to bring light to what occurs in the real world. #rwd #lungcancer #realworlddata #NSCLC #percisionmedicine https://lnkd.in/eJgetPxK

In This Issue: Joint FDA / CMS statement on LDTs Early pancreatic cancer Dx: A step forward COVID’s post-holiday bump What the increase in under-50 cancer is telling us #sensitiveandspecific #diagnostics #AIinDiagnostics #diagnostictesting #laboratorydevelopedtest #pancreaticcancer #AI #COVID #coronavirus #wastewatertesting #wastewatersurveillance

There's no denying that disparities in cancer screening leads to unequal outcomes in cancer diagnosis and treatment. Our minority communities and medically underserved populations face significant barriers to accessing routine cancer screening. Discover how addressing these challenges and developing strategies can prevent late-stage cancer diagnoses and improve survival rates. Read more about this pressing issue. #healthcaredisparities #equalhealth https://hubs.li/Q02q21g70